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Abstract: Retroviruses are a family of viruses that cause a broad range of pathologies in 
animals and humans, from the apparently harmless, long-term genomic insertion of 
endogenous retroviruses, to tumors induced by the oncogenic retroviruses and acquired 
immunodeficiency syndrome (AIDS) resulting from human immunodeficiency virus 
infection. Disease can be the result of diverse mechanisms, including tumorigenesis 
induced by viral oncogenes or immune destruction, leading to the gradual loss of CD4  
T-cells. Of the virally encoded proteins common to all retroviruses, the envelope (Env) 
displays perhaps the most diverse functionality. Env is primarily responsible for binding 
the cellular receptor and for effecting the fusion process, with these functions mediated by 
protein domains localized to the exterior of the virus. The remaining C-terminal domain 
may have the most variable functionality of all retroviral proteins. The C-terminal domains 
from three prototypical retroviruses are discussed, focusing on the different structures and 
functions, which include fusion activation, tumorigenesis and viral assembly and lifecycle 
influences. Despite these genetic and functional differences, however, the C-terminal 
domains of these viruses share a common feature in the modulation of Env ectodomain 
conformation. Despite their differences, perhaps each system still has information to share 
with the others. 
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1. Introduction 
Retroviruses are a diverse family of enveloped RNA viruses that can be broadly categorized into 
two groups based on genome complexity: the simple retroviruses and the complex retroviruses. All 
retrovirus genomes contain three major open reading frames that encode the viral structural and 
enzymatic proteins: gag, pol and env. In addition to the three major genes, an additional domain, pro, 
codes for the viral protease that is also present in all retroviruses. Distinguishing them from simple 
retroviruses, complex retroviruses also encode a number of accessory proteins that carry out additional 
virus-specific functions. 
The proteins common to all retroviruses (Gag, Pol, Pro and Env) have the same function regardless 
of the specific virus. Gag, the major structural protein, forms the viral capsid. Pol is the viral polymerase 
and is responsible for converting the single-stranded viral RNA genome into double-stranded  
DNA through its reverse transcriptase and RNaseH activities. Pro cleaves the Gag, Gag-Pro and  
Gag-Pro-Pol polyproteins into their mature forms and, in some viruses, also removes a C-terminal 
peptide from Env. Env is the receptor binding protein, facilitating the early steps in the virus-cell 
interaction and additionally drives the fusion process between the viral and cellular membranes. In 
mediating these basic replication functions, the retroviral proteins interact with numerous cellular 
cofactors that regulate the specificity and levels of protein function at various stages of viral 
replication. The remainder of this review focuses on the functional properties of the C-terminal tail 
(CTT) of the Env protein, a domain of Env that is common to all retroviruses, but one that varies 
widely in length and functionality. 
Env, the retroviral envelope protein, is the major viral protein present on the surface of retroviral 
particles. Env is translated as a polyprotein that is subsequently extensively post-translationally 
modified during trafficking through the biosynthetic pathway (reviewed for HIV in [1]). Briefly, Env 
is cleaved by a furin-like protease in the Golgi into its two subunits: the surface unit (SU) protein and 
the transmembrane (TM) protein. These two proteins remain non-covalently associated in most 
retroviruses and further assemble into a homotrimeric complex that is the active form of Env. Further, 
Env SU is cotranslationally modified at a relatively large number of N-linked and a few O-linked 
glycosylation sites, with the extent of glycosylation dependent on a particular viral Env sequence. The 
SU amino acid sequence exhibits a high degree of variation, with hypervariable regions interspersed in 
the primary sequence with relatively conserved regions, with the conserved regions predominantly 
composing the folding core of the protein, while the variable regions provide the outer surface of SU. 
Env TM is composed of three domains: the ectodomain; the membrane-spanning domain (MSD); 
and the C-terminal domain. The ectodomain of TM contains the fusion peptide at its N-terminus, 
which inserts into the cellular membrane post-receptor binding to begin the fusion process. 
Conformational changes in the ectodomain bring the cell and viral membranes in close contact, which 
ultimately results in the fusion of the cellular and viral lipid membranes. The primary function of the 
MSD is to anchor TM in the cellular/viral lipid membrane. While the specifics regarding the sequence 
and domain size differ for each individual retrovirus, the involved domains, and subdomains, are 
similar and have (predominantly) similar functions. The remaining domain, the TM C-terminal 
domain, is likely the most variable in terms of size (length) and functionality among the various 
retroviruses. The remainder of this review will focus on the Env C-terminal domain, or cytoplasmic 
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tail, from three well-characterized retroviruses: murine leukemia virus; Jaagsiekte sheep retrovirus; 
and human immunodeficiency virus (HIV).  
2. Retroviral C-Terminal Domains 
The majority of retroviruses have a short C-terminal domain (<50 amino acids) that is localized to 
the cellular cytoplasm or to the inside of the viral membrane (Figure 1). The lentiviruses, on the other 
hand, are unique among retroviruses in that they have long (~150 amino acid) C-terminal domains. 
While initially, the lentiviral TM was also thought to be a type I membrane protein [2], its membrane 
topology has recently become an emerging topic of research and debate [3–7]. Less controversial than 
the topology of the lentiviral C-terminal domain is its extensive functionality (recently reviewed  
in [1,8–10]), a trait that it shares with the C-terminal domains of other retroviruses.  
Figure 1. Representative retrovirus C-terminal domains. The C-terminal domains from 
Moloney murine leukemia virus (MuLV; 32 residues), Jaagsiekte sheep retrovirus (JSRV; 
45 residues) and human immunodeficiency virus (HIV-1; 151 residues) are presented to 
demonstrate the differences in the lengths of the domains among the different viruses. Each 
residue is represented by a rectangle colored by the side chain chemical property. Blue: 
basic; red: acidic; green: polar, not charged; yellow: hydrophobic. 
 
2.1. Murine Leukemia Virus (MuLV)  
Murine leukemia viruses (MuLV) are a group of viruses that belong to the Gammaretrovirus genus 
of the Retroviridae family. MuLV, like Jaagsiekte sheep retrovirus (JSRV), are simple retroviruses and 
have many exogenous and endogenous species. The particular focus here will be on the exogenous 
viruses that cause transmissible leukemia in mice, with a prototypical virus being Moloney MuLV, 
named for its discoverer [11]. MuLV integrates randomly into tissues in the preleukemic stage, but 
eventually causes tumors through the integration of the viral genome into unique sites of the cellular 
chromosomal DNA [12]. 
Like all retroviral Env proteins, the MuLV Env is responsible for receptor binding and membrane 
fusion. The importance of the cytoplasmic tail of MuLV in viral replication was initially recognized by 
the identification of a peptide, the R peptide, which is cleaved during Env polyprotein maturation [13]. 
The R peptide is comprised of the 16 C-terminal amino acids from MuLV Env and is cleaved 
during viral maturation [13]. Initial speculation suggested that R peptide cleavage might play a role in 
virus assembly [13]. More recent studies have since determined a more precise function for the R 
peptide. Early studies demonstrated that cleavage of the R peptide from MuLV Env was essential for 
the cell fusion activity of Env [14–16]. The addition of the MuLV cytoplasmic tail, and, specifically, 
the R peptide sequence, to a truncated simian immunodeficiency virus (SIV) Env protein [17] and 
influenza virus hemagglutinin protein [18] resulted in the inhibition of fusion activity. Studies that 
more specifically map the sequences involved in fusion inhibition by the R peptide have determined 
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that truncations greater than seven amino acids from the C-terminal end of the R peptide result in 
increased fusion activity and that a leucine at position 627 plays an important role in fusion  
inhibition [19]. Other studies have identified other sites in the cytoplasmic tail five or 10 amino acids 
upstream from the R peptide that can suppress the fusion inhibition exerted by the R peptide, where 
insertions in these regions led to fusion despite the presence of the R peptide [20]. Finally, a recent 
study has provided some insight into the mechanism by which the R peptide inhibits fusion. Using 
cryo-electron microscopy (cryo-EM) of MuLV Env proteins isolated from solubilized viral particles, 
Garoff and colleagues demonstrated that trimerization of the R peptide sequence serves to hold the legs 
of TM together in full-length uncleaved MuLV Env, preventing the activation of the TM for fusion. In 
marked contrast, the TM legs are distinctively separated in mature Env complexes in which the R 
peptide has been removed by proteolytic cleavage [21]. The modulation of Env ectodomain 
conformation by changes in the C-terminal domains is, as will be seen, an apparently common theme 
in the retrovirus Env function. 
2.2. Jaagsiekte Sheep Retrovirus (JSRV)  
JSRV is a retrovirus in the Betaretrovirus genus that is the causative agent of ovine pulmonary 
adenocarcinoma (OPA). JSRV is organized as a simple retrovirus, containing the gag, pol and env 
genes. JSRV also contains an additional open reading frame, ORF-x, of unknown significance, though 
it remains unclear if ORF-x encodes a functional protein [22,23]. OPA is a contagious disease resulting 
in tumors that originate in the distal lung and that shares clinical, radiological and histopathological 
features with a human cancer, bronchioalveolar cancer (BAC). As such, OPA and JSRV are an 
interesting model system by which to study the virological mechanisms of cancer, with potential 
applications for understanding human pulmonary carcinomas. 
Tumorigenesis of JSRV results from the transformation of differentiated lung epithelial cells in the 
alveoli and the bronchioli following infection. While the onset of OPA can be rapid under experimental 
conditions [24], in contrast to the acute oncogenic retroviruses that contain viral oncogenes derived from 
normal cellular genes, JSRV is not thought to contain a viral oncogene and has no sequence homology 
with any known cellular oncogene [25]. In addition, the deletion of the extra open reading frame,  
ORF-x, which would be the likely candidate for an oncogenic sequence, has no effect on cellular 
transformation in vitro, making it unlikely that it functions as a viral oncogene. Since it is clearly 
established that JSRV is the causative agent of OPA [26], but JSRV contains no sequences with 
homology to a known oncogene, how then is JSRV causing tumors in the lungs of sheep? 
The perhaps surprising answer is that JSRV induces tumor formation through the oncogenic 
properties of its Env protein. JSRV Env has been shown to transform multiple cell lines in vitro 
(reviewed in [22,23]). Importantly, JSRV Env is oncogenic in vivo, inducing lung tumors in mice [27] 
and sheep [28]. Cell transformation by JSRV Env is known to involve three signaling pathways: 
(1) the phosphatidylinositol-3 kinase (PI3K)-dependent and -independent Akt pathway; (2) the  
Raf-MEK-MAPK pathway; and (3) the RON-Hyal2 pathway [29]. It is unclear how JSRV 
activates both the Akt and the Raf-MEK-MAPK pathways, as no direct interactions between JSRV 
Env and constituents of those pathways have been observed. For the RON-Hyal2 pathway, JSRV Env 
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binds Hyal2, its entry receptor, which leads to Hyal2 degradation, which frees RON from Hyal2 
inhibition, allowing its activation and eventual cellular transformation [30].  
The TM subunit of the Env protein is the main determinant of cell transformation, with SU also 
having some effect. In particular, the cytoplasmic tail of TM is essential for the transformation of 
multiple cell lines [22,23]. This cytoplasmic tail contains a YXXM peptide motif that is a putative 
binding site for the p85 regulatory subunit of PI3K [31]. However, while the tyrosine residue of the 
YXXM motif is important for Env-mediated transformation, the motif itself does not appear to be 
directly involved in binding and activation of PI3K [29]. Recently, an additional function of the JSRV 
cytoplasmic tail has been determined, where truncations of the tail resulted in increased fusogenicity, 
which decreased the dependence on the normal low-pH requirement for fusion [32]. The  
fusion-enhancing truncations were accompanied by conformational changes in the ectodomain of TM, 
suggesting that the cytoplasmic domain of JSRV plays a regulatory role in the overall Env structure. 
2.3. Human Immunodeficiency Virus (HIV)  
In contrast to JSRV and MuLV, the cytoplasmic domain of the HIV TM protein, gp41, is long, 
comprising approximately 150 amino acid residues. Results from early topogenesis studies led to the 
view of gp41 (and, thus, Env as a whole) as a type I membrane protein, with an extracellular  
N-terminus, a single MSD and an approximately 150 amino acid-long cytoplasmic C-terminal tail 
(CTT) [2]. More recent studies, however, indicate that the CTT topology may be more dynamic and 
complex than previously thought, as most of the CTT sequence can be surface exposed in up to 30% of 
the Env protein expressed at the cell surface in transfected or infected cells [4]. In contrast, the CTT 
sequences appear to be exclusively internal in viral particles [4,5]. 
The presence of a very long CTT is not unique to HIV, as other lentiviruses, such as the simian 
immunodeficiency virus (SIV) and the equine infectious anemia virus (EIAV), have similarly long 
CTT sequences, at 150 and 200 amino acids, respectively [33]. The presence of a long CTT in most 
lentiviruses suggests an important functional role, as viruses do not generally replicate non-functional 
sequences. This functional importance is supported by the finding that the truncation of the CTT leads 
to in vivo suppression of viral replication in animal models [34]. A decade earlier, however, studies 
demonstrated that the CTT was dispensable for in vitro viral replication [35–37], leading to a long-held 
view that the CTT was not functionally important. This view was subsequently popularized by the 
finding that the truncation of the CTT led to increased Env incorporation into the virion, which was an 
important consideration at the time as a means of elevating the anti-Env immune response in 
experimental vaccines. It is now generally accepted that the CTT plays multiple important functional 
roles as a determinant of Env structural and functional properties in the virus lifecycle. However, there 
is very little direct experimental data to characterize the CTT structure; no full-length atomic level 
structures exist for any CTT sequences. 
2.3.1. CTT Structure 
Some CTT sequences have been studied structurally using peptide analogs and site-directed 
mutations. The most well-studied domains, the lentivirus lytic peptides (LLPs), are distinctive sequences 
that were initially identified by sequence scanning as having extraordinarily high hydrophobic moments 
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(Figure 2) [38]. Subsequent studies on peptide analogs of these domains demonstrated high levels of 
structural similarity with naturally occurring cytolytic peptides [39], as well as the ability of the 
peptides to alter cell membrane permeability [40]. Peptide analogs of these domains have been 
demonstrated by circular dichroism spectroscopy to be generally unstructured in aqueous buffer, but to 
rapidly adopt an alpha-helical structure in membrane lipid or membrane-mimetic environments [41–44]. 
Additionally, the LLP domains demonstrate remarkable conservation of physicochemical properties, 
arginine residues, and secondary structures in spite of substantial sequence diversity [44]. Finally, a 
very recent structural study of LLP2 peptides interacting with fully hydrated lipid membranes provides 
the first atomic-level insight into CTT-lipid interactions. LLP2 peptides were demonstrated to interact 
with and to embed into the interface of membranes whose lipid content mimicked that of the T-cell 
membrane, but the same LLP2 peptides interacted weakly with and did not insert into membranes 
whose lipid content mimicked the viral envelope [45]. 
Figure 2. Schematic of HIV Env. The HIV Env is presented, with a focus on the  
C-terminal tail (CTT). The immune reactive Kennedy epitope (KE) and the lentivirus lytic 
peptides (LLPs) are presented, along with the functional endocytic motifs (YXXϕ and LL). 
SU, surface unit; TM, transmembrane; MSD: membrane-spanning domain. 
 
2.3.2. CTT Membrane-interactive Domains are Conserved 
The conservation of the physicochemical properties of the CTT is particularly interesting for the 
LLP regions in light of their proposed membrane associating characteristics [41–43,46], where the 
hydrophobic moment and charge may complement one another. The hydrophobic moment has been 
proposed as a measure of the tendency of a sequence to prefer the chemically-complex interfacial 
boundary between the hydrocarbon membrane interior and the aqueous phase [47]. The preference for 
the chemically complex membrane-water interface is suggestive of a role for the LLP regions as 
membrane-anchoring sequences. The insertion of the LLP sequences into the interfacial region would 
have a physical influence on the local membrane environment through the introduction of local 
curvature stress, as well as by affecting the lateral pressure profile in the membrane interior [48–53]. 
These physical alterations of the membrane environment by membrane-interacting LLP peptides may 
provide an explanation for the modulation of Env ectodomain conformation induced by point 
mutations in the LLP [54]. For example, Kalia et al. reported that the mutation of two highly 
conserved arginine residues to glutamates in LLP1 or LLP2 markedly altered the overall Env 
conformation, antigenic and functional properties. While the Arg to Glu mutations introduced by  
Kalia et al. maintain the amphipathic potential of the LLP2 region, they alter the net charge of the 
region from +3 to −1 [54]. The resulting overall negative charge of the region may impact its 
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association with the negatively charged inner membrane leaflet by introducing charge-charge 
incompatibilities with the negatively charged phosphatidylserine headgroups. Differential association 
of LLP2 with the inner leaflet of the membrane would lead to a change in the local lateral pressure 
profile of the membrane, which, in turn, could lead to conformational changes in the protein by 
altering the arrangement of the transmembrane helices [49,51,53,55,56]. 
Recent experimental evidence supports this idea of differential membrane association, where 
Tristram-Nagle and colleagues determined the structure of wild-type (WT) and the previously 
characterized Arg to Glu mutant LLP2 peptides interacting with fully-hydrated lipid bilayers [45]. 
Their results demonstrated that the WT and mutant sequences associated and inserted differently into 
lipid membranes mimicking the composition of a T-cell membrane, with the Arg to Glu mutant 
sequence inserting ~15 angstroms (Å) more deeply into the hydrophobic core of the membrane, while 
the WT sequence was localized to the membrane-water interfacial region [45]. This study supports the 
concept that minor mutations in the LLP2 region can have a measurable impact on CTT-lipid 
association. Interestingly, the CTT has recently been demonstrated to also modulate the conformation 
of gp120 and the gp41 ectodomain in virus particles, where Env with a CTT deletion displayed a more 
open state, similar to the CD4-bound state [57,58]. This suggests the possibility that the CTT, and the 
LLP regions, in particular, evolves under pressure to maintain the “native” conformation of Env by 
maintaining specific, consistent interactions with the lipid membrane. 
The observed conservation of arginine residues in the CTT supports the demonstrated unique 
functionality for the CTT. Briefly, studies demonstrating a transient exposure of LLP2 sequences 
during the cell-cell fusion process are suggestive of a mechanism to prefer arginine conservation 
relative to replacement with lysine [59]. Arginine-rich peptides have been demonstrated to cross 
cellular membranes, while peptides with lysine instead of arginine do not [60–62]. In addition, 
arginine-rich peptides have been demonstrated to deliver soluble proteins into the cytoplasm of live 
cells [63]. The observed apparent traversing of the membrane by LLP2 during the fusion process 
would seem, then, to require the presence of arginine and limit substitutions by lysine. 
2.3.3. CTT Function  
In addition to the membrane lipid bilayer, the CTT has been shown to interact physically or 
functionally with other viral and cellular proteins. These functional interactions have been found to 
regulate: (i) Env incorporation into viral particles [64–69]; (ii) virion maturation [57,66,70,71];  
(iii) overall Env conformation and functional properties [54,57,58]; (iv) endocytosis of Env from the 
cell surface to late endosomes [72,73]; and (v) viral transcription and replication.  
2.3.3.1. Virion Env Incorporation  
Seminal studies by Freed and Martin demonstrated that the CTT was implicated in the 
incorporation of Env into virions through interactions with the matrix (MA) domain of Gag. The initial 
study used site-directed mutagenesis to demonstrate that mutations in specific amino acids in Gag MA 
resulted in deficiencies in the incorporation of Env with a full-length CTT [64]. The MA mutations did 
not, however, lead to reduced incorporation of heterologous retroviral Env proteins with naturally short 
CTT sequences. Further, specific truncation of CTT sequences to seven or 47 residues (from the 
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original 150) reversed the Env-incorporation block imposed by the MA mutations. This study 
demonstrated, for the first time, conclusive evidence of a functional role for the CTT through direct or 
indirect interactions with an intracellular partner, Gag MA. A later study provided evidence for a direct 
interaction between MA and the CTT [74].  
The role and localization of sequences important in the MA-CTT interaction has been further 
elucidated. A subsequent paper by the same authors demonstrated that truncating up to 56 residues 
from the CTT (leaving a 94-residue CTT) resulted in no Env incorporation in viruses containing MA 
mutations, leading to deficiencies in Env incorporation, but that truncations of 93 amino acids or 
greater (leaving only a 57-amino acid CTT) relieved the block caused by MA mutations, resulting in 
efficient Env incorporation [65]. Later papers from this group localized the MA-CTT interaction to 
LLP2 in the CTT [68] and further demonstrated that the interaction was crucial for Env virion 
incorporation in a cell type-specific manner [69].  
The CTT also appears to affect virion Env incorporation through interactions with the viral 
accessory protein, Nef. Functional interactions between Nef and the CTT dileucine motif also increase 
Env expression at the cell surface and virion incorporation [75]. This may be due to increased 
colocalization between Gag and Env in late endosomes, as shown for retroviral envelopes [76]. 
2.3.3.2. Virion Maturation  
Aiken and colleagues have further elucidated the interaction of the Env CTT with MA by 
examining the effect of pelleting immature HIV virus particles through detergent [77]. Pelleting 
particles through detergent strips away the viral lipid membrane in which the CTT is embedded, 
leaving viral protein cores. If the CTT and Pr55Gag interact, then gp41 should be associated with the 
pelleted viral cores. The results from this study demonstrated that the pelleted cores retained the major 
fraction of the gp41 found in untreated virions [77]. In contrast, gp41 did not remain associated with 
pelleted cores produced by similar detergent treatment of virions containing a truncated CTT [77]. 
Interestingly, a previous study using mature viral particles for a similar analysis demonstrated no 
association of the CTT with MA [78]. Thus, taken together, these results suggested that the association 
of the CTT with Pr55Gag was dependent on the maturation state of the virion. 
This maturation-dependent association of the CTT with Gag has been extended to examine the role 
of the CTT in viral fusion. It is well-established that HIV particles are not infectious until proteolytic 
cleavage of the Pr55Gag into its constituent domains (MA, CA and NC, predominantly). Using a 
reporter assay to measure virus-cell fusion, Wyma et al. demonstrate that immature virions are less 
fusogenic than mature virions in a manner that is dependent on the CTT, as truncations of the CTT 
resulted in identical fusogenicity of immature and mature viral particles [71]. More recent results 
suggest that the extreme C-terminus of the CTT, LLP1, modulates the maturation dependence of 
infectivity, while the deletion of this region does not affect the incorporation of Env into immature 
viral particles [66]. The CTT has also been shown to modulate the mechanical stability of immature 
virus particles relative to mature virus particles, presumably through its interactions with  
Pr55Gag [70]. These results collectively demonstrate that the interaction of the CTT and Gag have 
specific effects on the infectivity and structural stability of HIV particles. 
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2.3.3.3. Env Endocytosis  
The gp41 CTT of both SIV and HIV have long been known to contain endocytic signals. The first 
was demonstrated in SIV, where a consensus YXXΦ motif in the CTT was shown to interact with 
members of the adaptor protein medium chain family [73]. It has also been demonstrated  
that CTT sequences interact specifically with the AP-2 clathrin adaptor [79]. Most recently,  
Byland et al. demonstrated that the CTT contains two functional endocytic signals: a 711GYXXΦ 
motif located near the N-terminus of the CTT and a dileucine motif at the extreme C-terminus [72]. 
Their results indicate that in order to completely abolish endocytosis of Env from the cell surface to 
late endosomes, both motifs must be mutated, suggesting that both the N- and C-termini of the CTT are 
cytoplasmically localized to interact with the cellular endocytic machinery. 
2.3.3.4. Transcriptional Regulation and Virus Replication  
The CTT interacts with numerous cellular proteins (reviewed in [8–10]), and some of these 
associations function to modulate HIV-1 replication. Among the first cellular partners identified for the 
CTT was calmodulin. This interaction is associated with a decrease in the cellular protein synthesis 
activity [80,81]. Calmodulin, as a regulator of intracellular calcium concentration, regulates a variety 
of cellular enzymes and pathways, which has many potential outcomes on viral replication. The CTT 
has also been demonstrated to interact with p115-RhoGEF, a guanine nucleotide exchange factor 
(GEF) and activator of RhoA GTPase [82]. This functional interaction positively regulates HIV-1 
replication in human T-cells, possibly by relieving RhoA inhibition of HIV-1 gene expression, 
suggesting that gp41 counteracts the inhibition applied by p115/RhoA to maintain viral replication 
[82,83]. The CTT also interacts with the cellular protein, Luman, a transcription factor belonging to the 
CREB/ATF family, destabilizing the full-length precursor of the active form of Luman, thus 
counteracting its repressive effect on HIV-1 long terminal repeat (LTR) activation and relieving Gag 
and Env production [84]. More recently, the interaction between the CTT and the cellular prohibitins 
has been shown to contribute to virus replication in a cell type-dependent manner [85]. Prohibitins are 
expressed in many cellular compartments and are involved in multiple functions, such as 
mitochondrial functions or transduction pathways [86,87]. However, how their interaction with the 
CTT supports HIV-1 replication in certain cell types remains to be determined. Finally, the CTT also 
activates the NF-κB canonical pathway through interaction with TAK1 [88]. As the HIV-1 LTR 
contains NF-κB binding sites, these observations suggest a function for this interaction in regulating 
HIV-1 gene expression. The importance of this activation was revealed in conditions of sub-optimally 
activated T-lymphocytes in which a mutated envelope that could not interact with TAK1 affected virus 
replication [88]. 
2.3.3.5. CTT Influences Env Structure  
One of the earliest observations that the CTT could influence the overall Env structure was 
provided by the insight that viruses with CTT-deleted Env proteins could infect target cells in a  
CD4-independent manner [89]. Until that time, the paradigm for HIV infection of target cells was that 
gp120 binding to CD4 was necessary to induce conformational changes that allowed binding to the 
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coreceptor. Edinger et al. demonstrated that viruses with a CTT-deleted Env were able to infect  
CD4-negative, coreceptor-positive cells, suggesting a distinct conformation for Env that was 
dependent on the CTT. 
Initially, direct evidence for CTT-dependent alterations in the Env structure was provided by 
differential reactivity between CTT-deleted and wild-type Env with conformationally-dependent 
antibodies. Edwards et al. demonstrated that truncation of the CTT to 27 amino acids resulted in 
increased binding by monoclonal antibodies directed to both the CD4 binding site and the CD4− 
induced coreceptor binding site [90]. In Env with a full-length CTT, monoclonal antibodies directed to 
the coreceptor binding site only bound if the Env was preincubated with soluble CD4. The study also 
demonstrated the differential reactivity of conformational monoclonal antibodies directed at the 
ectodomain of gp41 between CTT-truncated and full-length CTT [90]. This study was the first to 
demonstrate that the CTT modulates the conformation of the overall Env structure, even in the  
non-covalently attached gp120, which is located on the opposite side of the membrane. 
Later studies demonstrated that point mutations in the CTT could exert similar conformational 
effects as CTT truncation. Kalia et al. demonstrated that alterations in the CTT could modulate the 
antigenic conformation of both the gp120 protein and the gp41 ectodomain. Instead of utilizing large 
deletions in the CTT, however, Kalia et al. demonstrated that the mutation of two conserved arginine 
residues in LLP2 to glutamate was sufficient to alter the conformation of both gp120 and the gp41 
ectodomain on the surface of Env-expressing cells [54]. The mutations were previously shown to have 
no effect on the levels of virion Env incorporation or viral replication, but decreased the efficiency of  
cell-cell fusion [91]. In addition to demonstrating antigenic distinctions between wild-type and mutant 
Env on the cell surface, differences were seen in the viral sensitivity to antibody-mediated 
neutralization by antibodies directed at the CD4 binding site, with the mutant virus demonstrating an 
approximately 40-fold decrease in neutralization sensitivity [54]. This study demonstrated that point 
mutations in the CTT were sufficient to alter overall Env conformation and, equally importantly, 
provided the first pieces of information regarding the critical nature of the conserved arginine residues 
in the LLP regions. 
A recent study has examined the effect of CTT-dependent alterations on Env antigenicity on the 
surface of viral particles [57]. Joyner et al. demonstrated that Env on immature virions (protease 
deleted) reacted differently to a number of conformationally-dependent monoclonal antibodies in a 
manner that was dependent on the presence or absence of the CTT [57]. This study provided the first 
direct evidence that the CTT plays a major role in modulating the conformation of the CTT in the 
virion in addition to on the cell surface. 
There is also recent structural evidence for the role of the CTT in the modulation of overall Env 
conformation. Subramaniam and colleagues determined the cryo-EM structures of CTT-deleted Env 
on the surface of SIV viral particles [58]. In comparison to wild-type virus containing the full-length 
CTT, CTT-deleted Env existed in a naturally “open” state, displaying large differences in the 
localization of electron density, which are consistent with the conformational changes normally 
associated with CD4 binding. This study, finally, provides the first conclusive structural evidence that 
the CTT sequences can, in addition to their functional roles, also serve to modulate the overall Env 
structure and function. 
  
Viruses 2014, 6 
 
 
294
3. Conclusions  
The C-terminal domains of varying retroviruses, which, at first glance, appear to have little in 
common with each other, aside from their position in the Env protein sequence, display some 
remarkably similar properties and functions. While the C-terminal domains from each protein have 
some very distinct functions, it is interesting to note that in all three proteins discussed here, the  
C-terminal domain has been experimentally implicated in the regulation of viral fusogenicity through 
the modulation of ectodomain TM conformation. While there is no sequence homology between these 
viral C-terminal domains and, thus, likely little structural similarity, this apparent functional homology 
serves as a striking reminder of the evolutionary relationship amongst this family of viruses. Perhaps it 
is important to consider, based on the comparisons and resulting similarities presented here for a single 
(small) domain of one of the essential genes (Env) from three retroviruses distinct from each other in 
sequence, species tropism and disease, that the retroviral research fields might still have much to learn 
from each other.  
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